High density lipoprotein (HDL) cholesterol changes were followed in 45 men with coronary heart disease who underwent 12 weeks of monitored aerobic exercise. Twenty-five patients who were taking a nonselective beta-receptor blocking drug (Group 1) did not demonstrate a significant change in HDL cholesterol after exercise (mean difference 2.8 ± 11.5 mg/dl), whereas patients who had not received a beta-blocking drug for ::::::3 months (Group 2) showed a significant increase (mean difference 8.4 ± 5.5 mg/dl; p < 0.05). However, for those patients in each group who had an initial HDL cholesterol level <35 mg/dl before exercise, there was a significant increase in HDL cholesterol levels (mean difference 8 ± 6.9 mg/dl [p < 0.02] and 11 ± 3 mg/ dl [p < 0.001] for Group 1 and Group 2, respectively) and a significant decrease in the low density lipoprotein (LDL)/ Most selective and nonselective beta]-adrenergic blocking drugs adversely affect serum high density lipoprotein (HDL) cholesterol and triglyceride concentrations (1,2). This is a potentially harmful side effect since HDL cholesterol is now known to be an important independent risk factor for the development of coronary artery disease (3). Physical activity, on the other hand, tends to elevate HDL cholesterol levels in both normal subjects and patients with coronary artery disease (4-9). The importance of increasing the HDL cholesterol level was demonstrated in the recent Helsinki Heart Study (10), which showed that an increase in HDL cholesterol by > 10% reduces future coronary events by 34%. It is not known whether the HDL cholesteroi-lowering properties of betal-blocking agents prevent the expected increase of this lipoprotein after long-term exercise. We therefore compared the lipid profile changes after completion of a 12 week monitored aerobic exercise program in Patients in Groups 1 and 2 achieved similar levels of exercise training after 12 weeks and were closely matched in age, medications, alcohol intake and smoking. The results indicate that among high risk patients (with an abnormally low HDL cholesterol level) exercise training can induce an augmentation of HDL cholesterol in those receiving a beta-blocking drug similar to that of patients not receiving such a drug. (J Am Coli Cardiol1988;12:662-8) patients with coronary artery disease who were or were not receiving a nonselective beta-blocker during the program.
High density lipoprotein (HDL) cholesterol changes were followed in 45 men with coronary heart disease who underwent 12 weeks of monitored aerobic exercise. Twenty-five patients who were taking a nonselective beta-receptor blocking drug (Group 1) did not demonstrate a significant change in HDL cholesterol after exercise (mean difference 2.8 ± 11.5 mg/dl), whereas patients who had not received a beta-blocking drug for ::::::3 months (Group 2) showed a significant increase (mean difference 8.4 ± 5.5 mg/dl; p < 0.05). However, for those patients in each group who had an initial HDL cholesterol level <35 mg/dl before exercise, there was a significant increase in HDL cholesterol levels (mean difference 8 ± 6.9 mg/dl [p < 0.02] and 11 ± 3 mg/ dl [p < 0.001] for Group 1 and Group 2, respectively) and a significant decrease in the low density lipoprotein (LDL)/ Most selective and nonselective beta]-adrenergic blocking drugs adversely affect serum high density lipoprotein (HDL) cholesterol and triglyceride concentrations (1, 2) . This is a potentially harmful side effect since HDL cholesterol is now known to be an important independent risk factor for the development of coronary artery disease (3) . Physical activity, on the other hand, tends to elevate HDL cholesterol levels in both normal subjects and patients with coronary artery disease (4) (5) (6) (7) (8) (9) . The importance of increasing the HDL cholesterol level was demonstrated in the recent Helsinki Heart Study (10) , which showed that an increase in HDL cholesterol by > 10% reduces future coronary events by 34%. It is not known whether the HDL cholesteroi-lowering properties of betal-blocking agents prevent the expected increase of this lipoprotein after long-term exercise. We therefore compared the lipid profile changes after completion of a 12 week monitored aerobic exercise program in HDL cholesterol ratio (mean difference -1.2 ± 1.6 [p < 0.05] and -0.9 ± 0.57 [p < 0.001], respectively). Patients in both groups who started exercise with an HDL cholesterollevel >35 mg/dl did not show a significant change after exercise.
Patients in Groups 1 and 2 achieved similar levels of exercise training after 12 weeks and were closely matched in age, medications, alcohol intake and smoking. The results indicate that among high risk patients (with an abnormally low HDL cholesterol level) exercise training can induce an augmentation of HDL cholesterol in those receiving a beta-blocking drug similar to that of patients not receiving such a drug.
(J Am Coli Cardiol1988; 12:662-8) patients with coronary artery disease who were or were not receiving a nonselective beta-blocker during the program.
Methods
Study patients. Fifty-five men aged 39 to 75 years (mean 62.6 ± 9) with a recent history of myocardial infarction (within 1 month) or nonsurgically correctable angina pectoris were consecutively enrolled into a phase II cardiac rehabilitation program after referral by their local medical physician. Patients with symptomatic congestive heart failure, significant pulmonary disease, unstable arrhythmia, peripheral vascular disease or severe hypertension were excluded from the study. Ten of these subjects were not included in the final study group because of left bundle branch block on the surface electrocardiogram (ECG) (n = 2), change in cardiac medication during the training period (n = 3), intervening acute myocardial infarction or coronary artery bypass surgery (n = 1), and failure to complete the program or attend ::::::75% of the sessions offered (n = 4). Twenty-five subjects had been receiving for ::::::4 weeks before entry into the study a nonselective beta-receptor blocking agent with no change in dose (Group O. Twenty patients had not received a beta-blocker for ::::::3 months before the study.
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All participants were placed on a Phase I American Heart Association diet 4 weeks before initiation of the exercise program and kept on a constant composition, isoweight diet. The composition was 30% fat, 15% protein, 55% carbohydrate and 300 mg/day cholesterol. The total daily caloric requirements are estimated on the basis of energy expenditure at rest and predicted activity level. A diary of alcoholic intake and cigarette smoking was kept by each patient and a dietary history was taken on a weekly basis. To measure compliance with the diet, the patients were weighed regularly and anthropometric data were obtained monthly. Skinfold thickness was measured by Harpenden calipers. The percent of body fat was predicted from the sum of biceps, triceps, subscapular and suprailiac readings (11) . Percent body fat is derived from the nomogram of Brozek and Keys (12) , which assumes that the density of lean tissue is constant for both genders and all ages.
Treadmill exercise test. Treadmill exercise testing was performed twice within a 3 week period before entry into the study and then monthly during and at the end of the rehabilitation period. A standard Bruce protocol was followed with the patient in a fasting state. A continuous 12 lead ECG was obtained throughout the test and recovery periods. The ECG data were computer-processed by a Marquette Electronic Data Loggers. All exercise tests were symptom-limited efforts, except when there was a horizontal or downward ST segment depression 2:0.3 m V, a lifethreatening arrhythmia or a >20 mm Hg decrease in systolic blood pressure associated with ST segment depression. Horizontal or downs loping ST segment depression 2: 1 mm that lasted 2:3 min into the recovery period was considered abnormal.
Oxygen uptake CV0 2 ) and carbon dioxide output before and during exercise were determined from the measurement of oxygen (with a paramagnetic oxygen analyzer) in the expired air using a Gould 2900 Energy Measurement Module. Expired volumes were determined by a mass flow meter. The metabolic cart was integrated with an Epson computer programmed to calculate oxygen consumption and carbon dioxide production continuously by breath by breath analysis, and at the point of maximal exercise (peak V0 2 ). Values were obtained every 20 s during baseline (2 min), warm-up (1 min) and exercise periods. Peak exercise occurred at the sign-or symptom-limited end point.
Serum lipid measurements. Blood was drawn on four occasions after a 12 to 14 h fast; three times before entry into the study and once at the end of the exercise program. Because the variability of individual determinations was insignificant, the last preentry lipid value (third blood sample drawn) was used for comparison with the postexercise level. Total cholesterol, HDL cholesterol and triglycerides were directly measured by an enzymatic cholesterol assay method adapted to the Technicon Auto A analyzer II continuousflow analytical instrument (13) . Total cholesterol was mea-ARVAN AND RUEDA NONSELECTIVE BETA-RECEPTOR BLOCKER EFFECT 663 sured by using cholesterol esterase (>440 Ulliter) to remove cholesterol from its esters and then oxidizing the free cholesterol with cholesterol oxidase (>500 U/liter) to produce hydrogen peroxide. The resulting indicator dye can be quantitated photometrically. High density lipoprotein cholesterol was determined similarly, except that serum low density and very low density lipoproteins were first selectively precipitated by a reagent containing 9.7 mmolliiter phosphotungstate, 0.4 molliiter magnesium ions, and 0.08% sodium azxide (preservative). The soluble HDL cholesterol fraction was then measured after the enzymatic steps for cholesterol determination.
The method of determining triglyceride levels depends on measuring glycerol liberated from lipase-induced hydrolysis of triglycerides. Through a series ofreactions using glycerol kinase, pyruvate kinase, and lactate dehydrogenase, reduced nicotinamide adenine dinucleotide is oxidized to nicotinamide adenine dinucleotide (reduced) (NADH). Triglyceride levels can be quantitated by relating the hydrolysis of 1 mole of triglyceride molecule for every mole of NADH oxidized in the final reaction. Assay controls, both normal and abnormal, are performed eight times a year through the College of American Pathologists for comprehensive evaluation. For the past year the variability of triglycerides, total cholesterol and HDL cholesterol was 0-0.8 (±SD), 0.1-1.8 (±SD), and 0.8-1.6 (±SD), respectively. A standard deviation (SD) of ±2 is considered accurate. Low density lipoprotein (LDL) cholesterol levels were calculated from the total cholesterol and HDL cholesterol determination as described by Friedwald et al. (14) .
Exercise program. The 12 week program consists of 30 to 45 min sessions of pedaling a stationary bicycle (Monark model 668), walking on a treadmill (Marquette) or using an arm ergometer (Monark) three times a week under nurse supervision and ECG telemetry. The initial training intensity is set at 50 to 75% of the peak oxygen consumption (PV0 2 ) level attained on exercise testing. This was progressively increased during the first month of the training program so that all subjects reached 70 to 85% of peak V0 2 at the end of 2 weeks. An exercise stress test was repeated every month and training conditions for the subsequent month were adjusted accordingly for each subject. In each session, exercise was preceded by a 10 min warm-up period and followed by a 10 to 15 min cooling down period.
The end points for a training response, as determined by a treadmill stress test, were an alteration in time of exercise, heart rate, blood pressure and rate-pressure product for sub maximal exercise at the end of the first stage of exercise, and peak V0 2 taken as the average of the last two 20 s values just before the test was ended.
Statistics. All data are reported as mean ±SD. The unpaired Student's t test was used for comparisons between groups and a paired Student's t test was used to compare pre-and post-exercise data within the same group. The required level of significance was a p value of <0.05. Covariate analysis using the general linear models procedure was carried out to assess the independent change of HDL cholesterol after controlling for triglycerides (15) .
Results
Clinical data (Table 1) . Group 1 patients were those who were taking a constant dose of a nonselective beta 1 -adrenergic blocking agent before and during the exercise program. Each individual had been taking a beta-blocking drug for ;:::4 weeks before starting the exercise rehabilitation program. Group 2 patients were those postmyocardial infarction patients who had not received a beta-blocker for ;:::3 months. There were 25 men in Group 1 with a mean age of 62 ± 8 years, and 20 men in Group 2 with a mean age of 63 ± l2 years. The attendance rate was 95 ± 3.3% for Group 1 and 96 ± 2% for Group 2. The average sustained heart rate during the 36 training sessions was, respectively, 81 ± 7.2% and 84 ± 4.2% of the target heart rate for Group 1 and Group 2 patients. Alcohol consumption, smoking history and preentry ejection fraction were similar for both groups, as were pre-and post-exercise weight and percent body fat groups. One patient in Group 2 was being treated with a diuretic during the exercise program.
Exercise data ( Table 2 ). Table 2 indicates that there was a comparable improvement of the variables related to training effect in the two groups. The time of exercise and peak \10 2 increased, whereas the heart rate at submaximal exercise decreased. The heart rate at rest and during peak exercise was significantly lower in Group 1 than in Group 2. This difference indicates the effectiveness of beta-adrenergic blockade in Group 1 patients.
Lipid data (Tables 3 and 4 Values are expressed as mean values ± SD. PV0 2 = peak oxygen consumption during exercise; a = mean of differences pre-and postexercise; ex = exercise; SM HR = submaximal heart rate before (Pre) and after (Post) exercise.
and Group 2 patients in Table 3 indicates that the total cholesterol, LDL cholesterol and triglycerides were not significantly altered in either group after completion of the program. However, the HDL cholesterol level increased significantly in Group 2 (mean change 8.4 ± 5.5 mg/dl; p < 0.05), whereas the change was insignificant in Group 1 (mean change 2.8 ± 11.5) after exercise conditioning. The LDLI HDL ratio decreased significantly only in Group 2 patients (-0.56 ± 0.7; p < 0.01). There was also no significant difference in lipid values between Groups 1 and 2 before the training program.
The HDL cholesterol response to exercise was further examined by subgrouping patients into those who had an initial abnormally low HDL cholesterol «35 mg/dl) and those who had a level within the normal range before the exercise program (Table 4) . A level of 35 mg/dl was chosen because this is the approximate lower limit of normal for middle-and older-aged men in the Framingham study (3) . Both Group 1 and Group 2 patients with an abnormally low preexercise HDL cholesterol level showed a significant improvement after exercise (mean increase 8 ± 6.9 mg/dl [p < 0.02] and 11 ± 3 [p < 0.001] for Group 1 and Group 2, respectively). Covariant analysis controlling for triglycerides indicated that the improvement of HDL cholesterol remained just as significant before controlling for triglyceride Tables I and 2. (p < 0.05 for adjusted means), and that increases of HDL cholesterol occurred independently of triglyceride changes (F = 0.35, p < 0.05). There was also an insignificant difference of triglyceride levels in groups with normal as compared with low HDL cholesterol, and there was no significant change in triglyceride levels before and after exercise in these subgroups. Conversely, when Group 1 and Group 2 patients were designated into low « 150 mg/dO and normal-high (> 150 mg/dl) triglyceride subgroups, there were no significant changes in triglycerides or HDL cholesterol levels after exercise except in Group 2 subjects who entered the study with a high baseline triglyceride level (296.6 ± 283 mg/dl). In this group there was a significant increase in HDL cholesterol (31 ± 4.4 to 39 ± 4 mg/dl pre-and postexercise, respectively; p < 0.001). However, the degree of triglyceride reduction after exercise for this subgroup did not reach statistical significance (169 ± 151 mg/dl postexercise, p > 0.05).
Patients whose initial HDL cholesterol level was in the
normal range did not show a significant change after finishing the program (-4.1 ± 9.5 and 4.8 ± 5 mg/dl, respectively for Group 1 and Group 2). The LDLlHDL ratio decreased significantly in the subgroups who had an abnormally low HDL cholesterol at the start of the exercise program, but did not change for those patients with an initial HDL cholesterol value within the normal range (Table 4) . There were no significant differences in the preexercise lipid values between Groups 1 and 2.
Discussion
Beta-blocking agents reduce HDL cholesterol, increase serum triglycerides and increase the cholesterol ratio (1, 14) . It is not clear whether these same changes persist during long-term exercise in subjects prone to coronary disease or those who have known coronary artery obstruction. During Table 3 .
acute exercise, nonselective beta-blockers attenuate the expected temporary increase of HDL cholesterol (16) . The purpose of the present study was to determine whether beta-blockers also prevent the expected increase in HDL cholesterol in patients with coronary artery disease during long-term exercise. Blood lipids and exercise. The HDL cholesterol level for all Group 1 patients (those taking a beta-blocker) did not change significantly after the 12 week aerobic conditioning program. In contrast, Group 2 patients (those not taking a beta-blocker) had a statistically significant increase in HDL cholesterol (20%) after completion of the same exercise program. The latter response was expected because HDL cholesterol is known to increase in highly trained athletes (17) (18) (19) as well as in subjects with coronary artery disease who have participated in a cardiac rehabilitation program (4-9). Our findings therefore appear to support the results of others that suggest that beta-adrenergic blocking drugs modify the expected improvement in HDL cholesterol after long-term exercise (20) (21) (22) .
It is generally accepted that the patients who have the lowest baseline HDL cholesterol level tend to show the greatest change after exercise (23) (24) (25) . For Group 1 and Group 2 patients who had initial HDL cholesterol level <35 mg/dl (3), there was a significant change not only in HDL cholesterol level (increase) but also in the LDLlHDL ratio (decrease). Within this subgroup, augmentation of the HDL cholesterol level after exercise was similar in patients receiving a beta-blocker (26%) and in those not receiving a beta-blocker (27%). In contrast, when the preexercise HDL cholesterol level was in the normal range (> 35 mg/dl), there was no significant increase after long-term exercise in either group. These findings indicate that HDL cholesterol tends to increase after exercise primarily in subjects with levels below the 20th percentile (26, 27) in whom the potential for developing additional coronary events is extremely high. In addition, nonselective beta-blocking drugs do not interfere with the improvement in HDL cholesterol levels in these types of patients. Previous preliminary studies (20) (21) (22) have not addressed the lipid responses to exercise in the highest risk individuals who are taking a beta-blocking agent. These individuals may in fact benefit from an exercise training program despite taking a drug that usually lowers HDL cholesterol.
Exercise conditioning. Both groups were well matched in age, gender, smoking, alcohol consumption and diet. The body weight and percent of body fat did not alter significantly from the preentry values. Both groups demonstrated a comparable positive exercise training effect from the 12 week program. The exercise variables that most consistently indicate a training effect in our program are the time of exercise, peak Y0 2 , and the heart rate at a matched submaximal exercise level. Despite reports to the contrary (28, 29) , beta-blocking agents did not prevent a training effect. Group 1 patients performed just as well as Group 2 patients despite a lower heart rate at rest and a lower peak exercise heart rate. This response is consistent with other reports (30) (31) (32) (33) indicating that patients receiving beta-blockers may achieve the same potential benefit from physical exercise as do patients who are not taking beta-blockers. The difference in the HDL cholesterol values cannot, therefore, be explained by failure of Group 1 patients to achieve exercise conditioning.
Mechanism of lipid changes. The mechanism whereby .exercise and nonselective beta-blockers alter HDL cholesterol and triglyceride levels is not clear. Both affect lipoprotein lipase, an enzyme that is responsible for catabolism of triglyceride-rich lipoproteins by means of beta]-and beta 2 - adrenoreceptor activation (2, 34, 35) . The surge of catecholamines during exercise increases lipoprotein lipase activity. In turn, the transfer of cholesterol to HDL lipoprotein is accelerated as plasma triglycerides are catabolized (36) . Beta-adrenoceptor blockade produces just the opposite effect (27, 37) . Perhaps the beta-agonistic effects of chronic exercise override the beta-blocking activity of nonselective agents to account for the improvement of HDL cholesterol levels seen in the present study. Catecholamine-induced changes, however, are usually only transient. High density lipoprotein cholesterol may return to normal within 15 min after recovery from strenuous exercise, as catecholamine and lipoprotein lipase levels return to normal (38) . Furthermore, we found that HDL cholesterol increased independent of triglyceride changes. Both of these factors argue against the explanation that lipoprotein lipase is the common denominator for the opposing action of exercise and betablockers on lipoproteins.
In addition to its effect on lipoprotein lipase, physical exercise increases lecithin-cholesterol acyltransferase (LeAT). Lecithin-cholesterol acyltransferase is an enzyme found in apoprotein AI, which converts nascent plasma HDL cholesterol to mature HDL cholesterol through esterification of cholesterol (39) . Mature HDL cholesterol is responsible for transport of cholesterol to the liver, where it is removed from the circulation. Nonselective beta-blockers, on the other hand, decrease the activity of LCAT (40) . Although there are no studies that have compared the relative importance of exercise versus beta-blockers with respect to the change in LCAT, it may be that the beneficial effect of exercise predominates over the negative influence of beta-blockers so that the net result is an elevation in LCAT.
Finally, there are several as yet unexplored pathways that may help to explain the opposing effects of exercise and beta-blockers on serum lipids. Alpha-as well as beta-cell receptor activity may be different during physical conditioning than after administration of beta-blockers. Both types of receptors influence lipid and lipoprotein levels (41) . Liver perfusion may be significantly different in conditioned pa-tients as opposed to those taking a beta-blocking drug. How this modifies the synthesis of very low density lipoproteins and the clearance of HDL cholesterol lipoproteins is unknown.
Limitations of the study. Patients taking a beta-blocking drug (Group 1) started at a lower HDL cholesterol level than did those who were not receiving a beta-blocker (Group 2). Consequently, the final HDL cholesterol level after exercise for high risk Group 1 patients (35.8 ± 11 mg/dl) still places these patients at high risk for coronary artery events according to the Framingham study (3) . Nevertheless, as shown in the National Heart, Lung, and Blood Institute's type II coronary intervention study (42) , a 10% increase in HDL cholesterol significantly reduces the progression of coronary artery lesions seen on angiography. Risk reduction, then, would probably occur in this group, although it is unclear to what degree. In addition, the present study was designed for 12 weeks of exercise. It is possible that over a longer period of exercise, HDL cholesterol levels may reach higher levels.
In Group 1 patients taking a beta-blocker who had a normal preexercise HDL cholesterol level, this level tended to decrease after exercise (p = NS). In contrast, the HDL cholesterol level tended to increase in Group 2 patients who had a normal preentry level (p > 0.05). Although it is possible that the decrease in HDL cholesterol levels for this subgroup of patients receiving a beta-blocker may represent an adverse drug effect, the downward trend may indicate only that a state of equilibrium had not been reached in patients recently started on medication. It has not been clearly established when HDL cholesterol levels reach a plateau after the start of nonselective beta-blocking therapy because the duration of most studies describing the effect of beta-blockers on the lipid profile has ranged from 4 weeks to 6 months (16, (43) (44) (45) .
Six patients were taking a calcium channel blocking medication (diltiazem) during the exercise study. According to previous reports (46, 47) , diltiazem does not adversely affect HDL cholesterol values, and we felt justified in including these patients in our study. One patient in Group 2 began treatment with a diuretic late in the course of his exercise program. Because it is unlikely that the diuretic unfavorably altered the serum lipids by virtue of its late administration, and because aerobic training and diet control can modify the adverse effects ofthiazides on lipids (48) , this patient was also kept in the study.
We cannot draw any conclusions as to the effect of exercise on plasma lipid levels in female patients who are taking a beta-adrenergic blocking drug. Prospective studies on exercise and lipid changes in women indicate that HDL cholesterol levels do not change after exercise (7, 49) . On the other hand, most studies in men have shown a consistent increase in HDL cholesterol after or during exercise (7, 24, 33) .
